_id
6915e7dbbc934aba376b1b27
Ticker
PSCR
Name
Proto Script Pharmaceutical Corp
Exchange
PINK
Address
9830 6th Street, Rancho Cucamonga, CA, United States, 91730
Country
USA
Sector
Industrials
Industry
Specialty Business Services
Currency
USD
Website
https://www.psphomecare.com
Description
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Last Close
0.0001
Volume
5000
Current Price
0.0001
Change
0
Last Updated
2026-01-06T09:36:57.062Z
Image
data:image/webp;base64,UklGRmABAABXRUJQVlA4IFQBAADwCQCdASpAAEAAPrFOnUmnJKKhMfxoAOAWCWIA0BBRJd+wDGcgYdZOhkOPNuoqhaxjRerBxPuGdZTgHHbsFo+lu+OY9P6yYKMZ5FAAZCj1PoZsPgIMzAiAAP7tByt1rZH/4toc5Qi1ISASrve4P9lBlZ5R7730yKyrIevkA+ms6bTeUnfLtZR2n0zfI5MOCorfebAM32Z3VhGuY57Rqp5cU5J2RrPiP2JsZnuYq5OFLc6LqwnkrF9SIZYjaOKG9x/kuLFFzgxSd/WPKJ78kun0ymUgYjkAGODe+PUdb+RupDmap7+wVidmfaP8TRqVVDq1AkVy0L7W8DfVszcsnRL24ByQxcxT+ONsVZp3tz7NC3zj0yiKLZLzXU8fAHdSfK5KBQKB6lLhrE/gDBcl5jGPSEwdFtU/uOxYb50v33u2YR25VLww56fNpHCFnJ5K96IWwAAA
Ipo Date
-
Market Cap
4914
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2017-09-30
Revenue
251974
Cost Of Revenue
38198
Gross Profit
213776
Operating Expenses
299231
Operating Income
-85455
Interest Expense
117503
Pretax Income
-283653
Net Income
-283653
Eps
-0.00577234455727898
Dividends Per Share
-
Shares Outstanding
49139998
Income Tax Expense
117503
EBITDA
-163555
Operating Margin
-33.91421337122084
Total Other Income Expense Net
-198198
Cash
-
Short Term Investments
-
Receivables
166438
Inventories
-
Total Current Assets
186746
Property Plant Equipment
40329
Total Assets
234557
Payables
155783
Short Term Debt
372745
Long Term Debt
-
Total Liabilities
1676380
Equity
-1441823
Bs_currency_symbol
USD
Depreciation
2595
Change In Working Capital
51031
Cash From Operations
-24304
Capital Expenditures
600
Cash From Investing
-600
Cash From Financing
24904
Net Change In Cash
-
Cf_currency_symbol
USD
PE
-
PB
-0.003408185193328169
ROE
19.673219250906666
ROA
-120.93137275800765
FCF
-24904
Fcf Percent
-0.09883559414860263
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
0
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
4
Growth Investing Score
3.5
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2017-09-30
Quarters > 0 > income Statement > revenue
251974
Quarters > 0 > income Statement > cost Of Revenue
38198
Quarters > 0 > income Statement > gross Profit
213776
Quarters > 0 > income Statement > operating Expenses
299231
Quarters > 0 > income Statement > operating Income
-85455
Quarters > 0 > income Statement > interest Expense
117503
Quarters > 0 > income Statement > pretax Income
-283653
Quarters > 0 > income Statement > net Income
-283653
Quarters > 0 > income Statement > eps
-0.00577234455727898
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
49139998
Quarters > 0 > income Statement > income Tax Expense
117503
Quarters > 0 > income Statement > EBITDA
-163555
Quarters > 0 > income Statement > operating Margin
-33.91421337122084
Quarters > 0 > income Statement > total Other Income Expense Net
-198198
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
166438
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
186746
Quarters > 0 > balance Sheet > property Plant Equipment
40329
Quarters > 0 > balance Sheet > total Assets
234557
Quarters > 0 > balance Sheet > payables
155783
Quarters > 0 > balance Sheet > short Term Debt
372745
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1676380
Quarters > 0 > balance Sheet > equity
-1441823
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-283653
Quarters > 0 > cash Flow > depreciation
2595
Quarters > 0 > cash Flow > change In Working Capital
51031
Quarters > 0 > cash Flow > cash From Operations
-24304
Quarters > 0 > cash Flow > capital Expenditures
600
Quarters > 0 > cash Flow > cash From Investing
-600
Quarters > 0 > cash Flow > cash From Financing
24904
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.00577234455727898
Quarters > 0 > ratios > PB
-0.003408185193328169
Quarters > 0 > ratios > ROE
19.673219250906666
Quarters > 0 > ratios > ROA
-120.93137275800765
Quarters > 0 > ratios > FCF
-24904
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.09883559414860263
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2017-06-30
Quarters > 1 > income Statement > revenue
114374
Quarters > 1 > income Statement > cost Of Revenue
84299
Quarters > 1 > income Statement > gross Profit
30075
Quarters > 1 > income Statement > operating Expenses
274268
Quarters > 1 > income Statement > operating Income
-244193
Quarters > 1 > income Statement > interest Expense
118979
Quarters > 1 > income Statement > pretax Income
-332567
Quarters > 1 > income Statement > net Income
-332567
Quarters > 1 > income Statement > eps
-0.006767745493192734
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
49139998
Quarters > 1 > income Statement > income Tax Expense
118979
Quarters > 1 > income Statement > EBITDA
-211352
Quarters > 1 > income Statement > operating Margin
-213.503943203875
Quarters > 1 > income Statement > total Other Income Expense Net
-88374
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
104130
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
116475
Quarters > 1 > balance Sheet > property Plant Equipment
42324
Quarters > 1 > balance Sheet > total Assets
166281
Quarters > 1 > balance Sheet > payables
159596
Quarters > 1 > balance Sheet > short Term Debt
237884
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1324452
Quarters > 1 > balance Sheet > equity
-1158171
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-332567
Quarters > 1 > cash Flow > depreciation
2236
Quarters > 1 > cash Flow > change In Working Capital
147478
Quarters > 1 > cash Flow > cash From Operations
-104696
Quarters > 1 > cash Flow > capital Expenditures
11645
Quarters > 1 > cash Flow > cash From Investing
-11645
Quarters > 1 > cash Flow > cash From Financing
59978
Quarters > 1 > cash Flow > net Change In Cash
-56363
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.006767745493192734
Quarters > 1 > ratios > PB
-0.004242896601624458
Quarters > 1 > ratios > ROE
28.714844353726694
Quarters > 1 > ratios > ROA
-200.00300695810105
Quarters > 1 > ratios > FCF
-116341
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.0171979645723679
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2017-03-31
Quarters > 2 > income Statement > revenue
138281
Quarters > 2 > income Statement > cost Of Revenue
30940
Quarters > 2 > income Statement > gross Profit
107341
Quarters > 2 > income Statement > operating Expenses
369075
Quarters > 2 > income Statement > operating Income
-261734
Quarters > 2 > income Statement > interest Expense
411593
Quarters > 2 > income Statement > pretax Income
-505868
Quarters > 2 > income Statement > net Income
-505868
Quarters > 2 > income Statement > eps
-0.0033556502725296702
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
150751109
Quarters > 2 > income Statement > income Tax Expense
411593
Quarters > 2 > income Statement > EBITDA
-92269
Quarters > 2 > income Statement > operating Margin
-189.2769071672898
Quarters > 2 > income Statement > total Other Income Expense Net
-244134
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
56363
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
104796
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
196170
Quarters > 2 > balance Sheet > property Plant Equipment
32915
Quarters > 2 > balance Sheet > total Assets
229085
Quarters > 2 > balance Sheet > payables
131188
Quarters > 2 > balance Sheet > short Term Debt
69143
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1054689
Quarters > 2 > balance Sheet > equity
-825604
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-505868
Quarters > 2 > cash Flow > depreciation
2006
Quarters > 2 > cash Flow > change In Working Capital
57825
Quarters > 2 > cash Flow > cash From Operations
-214978
Quarters > 2 > cash Flow > capital Expenditures
9376
Quarters > 2 > cash Flow > cash From Investing
-9376
Quarters > 2 > cash Flow > cash From Financing
277210
Quarters > 2 > cash Flow > net Change In Cash
52856
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.0033556502725296702
Quarters > 2 > ratios > PB
-0.01825949353443055
Quarters > 2 > ratios > ROE
61.27247445506563
Quarters > 2 > ratios > ROA
-220.82109260754743
Quarters > 2 > ratios > FCF
-224354
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.6224499388925449
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2016-12-31
Quarters > 3 > income Statement > revenue
100349
Quarters > 3 > income Statement > cost Of Revenue
99732
Quarters > 3 > income Statement > gross Profit
617
Quarters > 3 > income Statement > operating Expenses
380187
Quarters > 3 > income Statement > operating Income
-379570
Quarters > 3 > income Statement > interest Expense
411593
Quarters > 3 > income Statement > pretax Income
-7264209
Quarters > 3 > income Statement > net Income
-7264209
Quarters > 3 > income Statement > eps
-0.07735101891914857
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
93912260
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-378024
Quarters > 3 > income Statement > operating Margin
-378.24990782170227
Quarters > 3 > income Statement > total Other Income Expense Net
-6884639
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3507
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
140000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
144646
Quarters > 3 > balance Sheet > property Plant Equipment
25545
Quarters > 3 > balance Sheet > total Assets
170191
Quarters > 3 > balance Sheet > payables
157490
Quarters > 3 > balance Sheet > short Term Debt
51290
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
489927
Quarters > 3 > balance Sheet > equity
-319736
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-7264209
Quarters > 3 > cash Flow > depreciation
1546
Quarters > 3 > cash Flow > change In Working Capital
438585
Quarters > 3 > cash Flow > cash From Operations
40881
Quarters > 3 > cash Flow > capital Expenditures
12226
Quarters > 3 > cash Flow > cash From Investing
-12226
Quarters > 3 > cash Flow > cash From Financing
-30944
Quarters > 3 > cash Flow > net Change In Cash
-2289
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.07735101891914857
Quarters > 3 > ratios > PB
-0.02937181299572147
Quarters > 3 > ratios > ROE
2271.939662721745
Quarters > 3 > ratios > ROA
-4268.268592346247
Quarters > 3 > ratios > FCF
28655
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.28555341856919353
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
49139998
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
228485
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
45
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-
Annuals > 1 > income Statement > net Income
-
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
49139998
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
-
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
-
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
-
Annuals > 1 > balance Sheet > equity
-
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-
Annuals > 1 > cash Flow > depreciation
236558
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
-
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
45
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-
Annuals > 2 > income Statement > net Income
-
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
49139998
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
-
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
-
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-
Annuals > 2 > cash Flow > depreciation
206297
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
-
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
45
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
49139998
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
-
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-
Annuals > 3 > cash Flow > depreciation
171860
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-
Annuals > 3 > cash Flow > capital Expenditures
-
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
45
Valuation > metrics > PE
-0.00577234455727898
Valuation > metrics > PB
-0.003408185193328169
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
19.673219250906666
Profitability > metrics > ROA
-151.89241001145942
Profitability > metrics > Net Margin
-1.1257232889107607
Profitability > final Score
39
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.7272580274546182
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.35333227378681925
Liquidity > metrics > Quick Ratio
0.35333227378681925
Liquidity > final Score
28
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
22
Prev Risks > 1
27
Prev Risks > 2
26
Prev Liquidities > 0
25
Prev Liquidities > 1
59
Prev Liquidities > 2
45
Updated At
2026-01-20T22:25:48.304Z
Earnings History > 0 > period
2017-09-30
Earnings History > 0 > report Date
2017-09-30
Earnings History > 0 > date
2017-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0058
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2017-06-30
Earnings History > 1 > report Date
2017-09-30
Earnings History > 1 > date
2017-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0058
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2017-03-31
Earnings History > 2 > report Date
2017-06-30
Earnings History > 2 > date
2017-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0068
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2016-12-31
Earnings History > 3 > report Date
2017-03-31
Earnings History > 3 > date
2016-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0034
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2016-09-30
Earnings History > 4 > report Date
2016-12-31
Earnings History > 4 > date
2016-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0217
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2016-06-30
Earnings History > 5 > report Date
2016-06-30
Earnings History > 5 > date
2016-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0018
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2016-03-31
Earnings History > 6 > report Date
2016-06-30
Earnings History > 6 > date
2016-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0018
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2015-12-31
Earnings History > 7 > report Date
2016-03-31
Earnings History > 7 > date
2015-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.0005
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.0005
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2015-09-30
Earnings History > 8 > report Date
2015-12-31
Earnings History > 8 > date
2015-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0002
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0002
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2015-06-30
Earnings History > 9 > report Date
2015-09-30
Earnings History > 9 > date
2015-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0002
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0002
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2015-03-31
Earnings History > 10 > report Date
2015-06-30
Earnings History > 10 > date
2015-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0004
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2014-12-31
Earnings History > 11 > report Date
2015-03-31
Earnings History > 11 > date
2014-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0067
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2014-09-30
Earnings History > 12 > report Date
2014-11-30
Earnings History > 12 > date
2014-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0007
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2014-06-30
Earnings History > 13 > report Date
2014-08-31
Earnings History > 13 > date
2014-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0002
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2014-03-31
Earnings History > 14 > report Date
2014-05-31
Earnings History > 14 > date
2014-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0005
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2013-12-31
Earnings History > 15 > report Date
2014-02-28
Earnings History > 15 > date
2013-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0003
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2013-09-30
Earnings History > 16 > report Date
2013-11-30
Earnings History > 16 > date
2013-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0001
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2013-06-30
Earnings History > 17 > report Date
2013-08-31
Earnings History > 17 > date
2013-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0002
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A4 Cutting-Edge Research Sessions at PSCR 2021 National Institute of Standards and Technology (.gov)
Read more →(Last Updated 2017-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Proto Script Pharmaceutical Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2017-09-30
EPS Actual
-0.0058
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2017-09-30)
(Last Updated 2017-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2017-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2017-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.